NCT06642857View on ClinicalTrials.gov

Multi-omics Based Prediction of Treatment Response to Immunotherapy Combined with Chemotherapy in Advanced Gastric/Gastroesophageal Junction Cancer.

RecruitingOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

March 25, 2024

Primary Completion Date

February 1, 2026

Study Completion Date

February 1, 2026

Conditions

Advanced Gastric CarcinomaAdvanced Gastroesophageal Junction Adenocarcinoma

Interventions

OTHER

Peripheral blood, tougue coating, saliva, and feces

Peripheral blood, coating, saliva, and feces on the tongue and clinical data of patients with advanced gastric cancer patients who received chemotherapy combined with immunotherapy will be collected.

Trial Locations (1)

310000

RECRUITING

Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou

All Listed Sponsors

lead

Xiangdong Cheng

OTHER